Dana-Farber Cancer Institute is retracting six papers and correcting 31 manuscripts after an alleged data manipulation review involving four of its top scientists. The institute also mentioned scores of studies are under review, including several authored by CEO Laurie Glimcher, COO William Hahn, Irene Ghobrial, and Kenneth Anderson. The review stemmed from potential errors flagged by a blogger, with some cases deemed “credible” after investigation. Correcting errors and retracting incorrect data is important to restore trust, according to a biological researcher at Johns Hopkins University. The cancer institute confirmed that corrections are in progress and that additional manuscripts are under examination.
Source link
Dana Farber says 6 studies to be retracted and 31 corrected
